Henipavirus infection of the central nervous system

Brian E Dawes1,2, Alexander N Freiberg2,3,4

  • 1Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas, 77555, USA.

Pathogens and Disease
|April 16, 2019
PubMed

Insights

Nipah virus (NiV) and Hendra virus cause severe disease, with NiV posing a pandemic threat. Understanding NiV neuropathogenesis and innate immune responses is crucial for developing effective treatments and preventing future outbreaks.

Area of Science:

  • Virology
  • Immunology
  • Neurology

Background:

  • Nipah virus (NiV) and Hendra virus are highly pathogenic zoonotic viruses in the Paramyxoviridae family.
  • These henipaviruses cause severe respiratory and encephalitic disease with high mortality rates.
  • NiV is a potential pandemic threat, yet its neuropathogenesis remains poorly understood.

Purpose of the Study:

  • To review the clinical disease, pathology, and pathogenesis of NiV infection.
  • To focus on central nervous system (CNS) infection and the need for a relapsed CNS infection model.
  • To examine innate immune responses to NiV in vitro and in the CNS.

Main Methods:

  • Literature review of existing studies on NiV and Hendra virus.
  • Analysis of clinical data, pathology reports, and experimental findings.
  • Synthesis of information on neuropathogenesis and immune responses.

Main Results:

  • Neuropathogenesis involves both vascular disease and direct brain infection, with relative contributions unclear.
  • Respiratory disease stems from vasculitis and respiratory epithelial cell infection.
  • Innate immune responses are likely linked to persistent CNS infection.

Conclusions:

  • Further research is needed to elucidate the precise mechanisms of NiV neuropathogenesis.
  • Developing a model for relapsed CNS infection is essential for studying persistent henipavirus infections.
  • Understanding innate immunity is critical for managing NiV-related CNS disease.

Related Concept Videos